Home (Cancer Genomics & Proteomics)
Cancer Genomics & Proteomics (CGP) is an international online-only open access, peer reviewed bimonthly journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to experimental and clinical cancer research. CGP was established in 2004.
Impact factor (2019): 3.280
Total articles: 47
Total cites: 894
Special issue of CANCER GENOMICS AND PROTEOMICS on ‘DNA Replication,
Genome Stability and Cell Cycle Control.
Dedicated to the study of DNA replication and the maintenance of genome stability, processes that are intrinsically linked to the cell cycle and cell division. This issue will focus on mechanisms that ensure proper DNA replication including licensing and replication machineries as well as cell cycle dynamics and genomic instability. The latter is now considered to play a key role in carcinogenesis.
Topics include but are not limited to:
- Genomic instability in precancerous and cancer cells
- DNA replication
- Replication licensing
- DNA damage response
- Chromosomal instability
- DNA repair pathways
- p53 signaling
- Cell cycle checkpoints
- Oncogene-induced genomic instability
- Proteomic instability
- Role of microRNAs in cancer
- Homologous recombination deficiency (HRD)
- Mismatch-repair (MMR) deficiency
- Microsatellite instability (MSI)
Deadline for manuscript submission: April 7, 2021. Publication in May 2021.
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389